Greenwich Lifesciences Stock Forecast - Triple Exponential Smoothing
| GLSI Stock | USD 13.40 0.19 1.44% |
The Triple Exponential Smoothing forecasted value of Greenwich Lifesciences on the next trading day is expected to be 13.36 with a mean absolute deviation of 0.35 and the sum of the absolute errors of 20.42. Greenwich Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Greenwich Lifesciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
Greenwich |
Greenwich Lifesciences Triple Exponential Smoothing Price Forecast For the 14th of December 2024
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Greenwich Lifesciences on the next trading day is expected to be 13.36 with a mean absolute deviation of 0.35, mean absolute percentage error of 0.18, and the sum of the absolute errors of 20.42.Please note that although there have been many attempts to predict Greenwich Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Greenwich Lifesciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Greenwich Lifesciences Stock Forecast Pattern
| Backtest Greenwich Lifesciences | Greenwich Lifesciences Price Prediction | Buy or Sell Advice |
Greenwich Lifesciences Forecasted Value
In the context of forecasting Greenwich Lifesciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Greenwich Lifesciences' downside and upside margins for the forecasting period are 10.29 and 16.43, respectively. We have considered Greenwich Lifesciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Greenwich Lifesciences stock data series using in forecasting. Note that when a statistical model is used to represent Greenwich Lifesciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.018 |
| MAD | Mean absolute deviation | 0.3461 |
| MAPE | Mean absolute percentage error | 0.0251 |
| SAE | Sum of the absolute errors | 20.4196 |
Predictive Modules for Greenwich Lifesciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Greenwich Lifesciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Greenwich Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Greenwich Lifesciences
For every potential investor in Greenwich, whether a beginner or expert, Greenwich Lifesciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Greenwich Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Greenwich. Basic forecasting techniques help filter out the noise by identifying Greenwich Lifesciences' price trends.View Greenwich Lifesciences Related Equities
| Risk & Return | Correlation |
Greenwich Lifesciences Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Greenwich Lifesciences' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Greenwich Lifesciences' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Greenwich Lifesciences Market Strength Events
Market strength indicators help investors to evaluate how Greenwich Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Greenwich Lifesciences shares will generate the highest return on investment. By undertsting and applying Greenwich Lifesciences stock market strength indicators, traders can identify Greenwich Lifesciences entry and exit signals to maximize returns.
Greenwich Lifesciences Risk Indicators
The analysis of Greenwich Lifesciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Greenwich Lifesciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting greenwich stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.45 | |||
| Standard Deviation | 3.1 | |||
| Variance | 9.58 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Greenwich Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Greenwich Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Greenwich Lifesciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Greenwich Lifesciences Stock:Check out Historical Fundamental Analysis of Greenwich Lifesciences to cross-verify your projections. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Return On Assets (0.72) | Return On Equity (1.24) |
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.